Xilio Therapeutics, Inc. 8-K

What Happened
Xilio Therapeutics, Inc. (XLO) filed a Current Report on Form 8‑K on March 9, 2026 (Item 7.01, Regulation FD Disclosure) announcing that it has posted its current corporate investor slide presentation to the “Investors & Media” section of its website (https://ir.xiliotx.com). A copy of the slide deck dated March 9, 2026 is furnished as Exhibit 99.1 to the filing. The company explicitly states that information on its website is not incorporated by reference into the 8‑K. The filing does not report earnings, executive changes, mergers, or other financial results.

Key Details

• Form 8‑K filed: March 9, 2026 (Item 7.01 — Regulation FD Disclosure).
• Exhibit furnished: 99.1 — Corporate slide presentation dated March 9, 2026.
• Presentation posted at: https://ir.xiliotx.com (Investors & Media).
• Inline XBRL cover page included as Exhibit 104 (interactive data file).

Why It Matters
This filing makes Xilio’s latest investor presentation publicly available and indicates the company is broadly distributing business updates in compliance with Regulation FD so all investors have equal access. Retail investors should review the posted slide deck for the company’s most recent strategic, pipeline, and corporate updates. Note that this 8‑K does not include financial results, management changes, or transaction announcements — it is a disclosure of the presentation itself.